Détention brevets de la classe C12N 15/45

Brevets de cette classe: 165

Historique des publications depuis 10 ans

6
5
4
8
8
7
10
7
21
11
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Propriétaires principaux

Proprétaire
Total
Cette classe
The United States of America, as represented by the Secretary, Department of Health and Human Services
2838
5
Glaxosmithkline Biologicals S.A.
1635
4
ID Pharma Co., Ltd.
43
4
Intervet International B.V.
1275
4
Boehringer Ingelheim Vetmedica GmbH
1267
3
Centre National de La Recherche Scientifique
10350
3
Icahn School of Medicine at Mount Sinai
936
3
The Research Foundation for Microbial Diseases of Osaka University
70
3
The University of Tokyo
4153
3
Beijing Cell-fusion Biotechnology Co., Ltd.
6
3
Shanghai King-cell Biotechnology Co. Ltd.
6
3
Shenzhen Rhegen Biotechnology Co., Ltd.
40
3
Wuhan Rhegen Biotechnology Co., Ltd.
31
3
Mayo Foundation for Medical Education and Research
3191
2
Cornell University
3288
2
Institute of Microbiology, Chinese Academy of Sciences
117
2
Merial Limited
117
2
Pontificia Universidad Catolica de Chile
286
2
Research Institute at Nationwide Children's Hospital
555
2
Universite Laval
715
2
Autres propriétaires 107